Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 14, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) held through various employee benefit trusts and plans.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share transaction details within employee benefit schemes.
Material Changes and Transactions
- Share Transfers: On October 10, 2003, the GlaxoSmithKline Employee Trust transferred 23,622 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Share Purchases: On October 8, 2003, the SmithKline Beecham Employee Benefit Trust purchased 1,253 Ordinary Shares at £12.89 per share for the Bonus Investment Plan and 1,663 Ordinary Shares at £12.85 per share for the Annual Investment Plan.
- ADR Holdings: As of October 10, 2003, the GlaxoSmithKline US Retirement Savings Plan's holdings increased from 18,761,661 to 18,818,366 Ordinary Share ADRs at an average price of $43.35.
Management Commentary and Risks
The filing notes that Directors Dr. J-P Garnier and Mr. J.D. Coombe are interested in shares held by the GSK Trust and the Employee Benefit Trust in the same capacity as other employees. Dr. J-P Garnier is also noted as potentially interested in shares held by the US Retirement Savings Plan. No specific risks, contingencies, or unusual items regarding the company's operations are disclosed in this text.
Investor Verification Checklist
- Verify the total number of shares held by directors through discretionary trusts versus direct ownership.
- Confirm the impact of the reported share transfers and purchases on the company's total outstanding share count.
- Review the pricing of recent share transactions (£12.85–£12.89 and $43.35) against the market price on the transaction dates.
- Check subsequent filings for any changes in the composition of the employee benefit trusts.